JWM
LGND icon

JPL Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

JPL Wealth Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.1K Buy
+246
New +$48.7K 0.01% 244
2025
Q4 		– Sell
-296
Closed -$52.4K – 668
2025
Q3 		$52.4K Buy
+296
New +$44K 0.01% 245

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

JPL Wealth Management's LGND Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2026: 246 shares worth $49.1K. The stake represents 0.01% of the portfolio and ranks #244 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in LGND as recently as Q3 2025.

JPL Wealth Management first reported a position in LGND in Q3 2025 and has held it in 2 quarters since. The position peaked at $52.4K in Q3 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • JPL Wealth Management held 246 shares of Ligand Pharmaceuticals worth $49.1K as of Q1 2026.
  • Ligand Pharmaceuticals was a new JPL Wealth Management position in Q1 2026.
  • Ligand Pharmaceuticals made up 0.01% of JPL Wealth Management's portfolio in Q1 2026, its #244 holding.
  • JPL Wealth Management first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • JPL Wealth Management's Ligand Pharmaceuticals position peaked at $52.4K in Q3 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.